Abstract

Partially hydrolysed, prebiotic supplemented whey formula for the prevention of allergic manifestations in high risk infants: a multicentre double-blind randomised controlled trial. Rights and permissions Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. Partially hydrolysed, prebiotic supplemented whey formula for the prevention of allergic manifestations in high risk infants: a multicentre double-blind randomised controlled trial [RAW_REF_TEXT] Robert Boyle 1 , Nick Brown2 , Wen Chin Chiang3 , Chua Mei Chien3 , Michael Gold4 , Jonathan Hourihane5 , Jane Peake6 , Patrick Quinn4 , Raj Rao7 , Peter Smith8 , Mimi Tang9 , John Ziegler10 & John Warner1 [/RAW_REF_TEXT] Clinical and Translational Allergy volume 10, Article number: 48 (2020) Cite this article [RAW_REF_TEXT] 86 Accesses 1 Altmetric Metrics details The original article was published in Clinical and Translational Allergy 2015 5:

Details

Title
Retraction Note to: Partially hydrolysed, prebiotic supplemented whey formula for the prevention of allergic manifestations in high risk infants: a multicentre double-blind randomised controlled trial
Author
Boyle, Robert; Brown, Nick; Wen Chin Chiang; Chua Mei Chien; Gold, Michael; Hourihane, Jonathan; Peake, Jane; Quinn, Patrick; Rao, Raj; Smith, Peter; Tang, Mimi; Ziegler, John; Warner, John
Pages
1
Section
Retraction Note
Publication year
2020
Publication date
2020
Publisher
John Wiley & Sons, Inc.
e-ISSN
20457022
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2461865814
Copyright
© 2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.